Appearing as a significant advance in the fight against obesity, the drug is generating considerable interest . It combines effects of two recognized GLP-1 receptor agonists, dulaglutide , and an unique glucose-dependent hormonal component. Early study findings have shown significant fat reduction in patients with a high BMI , perhaps providing a